Tom Powles/X
Apr 9, 2025, 04:45
Tom Powles: Promising Data on SABR in Renal Cancer to Delay Systemic Therapy
Tom Powles, Professor at the University of London, shared a post on X:
“Data exploring SABR in renal cancer to delay systemic therapy in selected patient looks promising and is being used. Brian Rini highlights the pateint selections means good outcomes will occur with surveillance. Randomisation with OS should be the endpoints . Trials awaited.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 4, 2025, 10:29
May 4, 2025, 10:01
May 4, 2025, 09:25
May 4, 2025, 09:00
May 4, 2025, 08:54